Fundamental Research Division
For the longest time, the treatment of irradiation and radionuclide contamination was only a concern for the nuclear workforce. Since more than a decade, the threat of a terrorist attack (CBRNe risk) that could involve radionuclides (NR) has been a reality, which furthermore raises the question of treating the public.
In this file you will find information regarding the treatment of: external radiation (radioprotective treatments), skin contamination (decontamination), and internal contamination (decorporation treatments).
Several types of exposure to radioactive compounds exist. A distinction is made between radioactive contamination and irradiation from exposure to ionizing radiation.
Radioprotective agents are compounds administered before or after irradiation, to prevent or reduce the effects of ionizing radiation.
Decontamination is the safe elimination of a hazardous substance from the surface of an object.
Internal exposure continues as long as the radioactive substance has not been eliminated naturally by the body, or through radioactive decay. Treatment with a decorporating agent is aimed at promoting natural elimination.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.